07:31 AM EDT, 03/17/2025 (MT Newswires) -- Arcutis Biotherapeutics ( ARQT ) unit Arcutis Canada said Monday that Health Canada has approved the PrZoryve cream to treat mild to moderate atopic dermatitis in adults and children aged six years and above.
Atopic dermatitis is a relapsing skin condition that usually presents early in life.